Combination of RNA Interference and Virus Receptor Trap Exerts Additive Antiviral Activity in Coxsackievirus B3-induced Myocarditis in Mice
The Journal Of Infectious DiseasesPeer ReviewedElisabeth Stein +102014Journals
Coxsackievirus B3 (CVB3) is a major heart pathogen against which no therapy exists to date. The potential of a combination treatment consisting of a proteinaceous virus receptor trap and an RNA interference-based component to prevent CVB3-induced myocarditis was investigated.
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support